RxDoctor Payments Data

Ashley Lowe

Family · Darlington, SCNPI 1194768184

Payments from drug & device makers

$1,708in general payments, 2019–2025

Across 117 payments — averaging $14.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$352
  • Novo Nordisk$208
  • Johnson & Johnson$114
  • Xeris Pharmaceuticals, Inc.$113
  • Merck$89
  • AstraZeneca$88
  • plus $744 from 22 others

What the payments were for

  • Food & beverage$1,708100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,708 in reported general payments places this provider in the 75th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide54$58,390
EliquisApixaban67$50,366
TrulicityDulaglutide43$46,750
JardianceEmpagliflozin27$30,560
JanuviaSitagliptin Phosphate26$28,400
OzempicSemaglutide17$22,417
Breo ElliptaFluticasone/Vilanterol18$11,424
FarxigaDapagliflozin Propanediol13$9,363
InvokanaCanagliflozin13$8,257
Aimovig AutoinjectorErenumab-Aooe11$7,958
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$6,785
Lantus SolostarInsulin Glargine,hum.Rec.Anlog50$6,060
Pimecrolimus13$5,621
Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp18$3,938
Novolog FlexpenInsulin Aspart14$2,795

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$68$105,14097 claims
PfizerEliquis$59$50,36667 claims
MerckJanuvia$89$28,40026 claims
Novo NordiskOzempic$208$22,41717 claims
GSKBreo Ellipta$79$11,42418 claims
AstraZenecaFarxiga$88$9,36313 claims
Johnson & JohnsonInvokana$114$8,25713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,248 family providers in South Carolina.

Other family in Darlington

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →